insights_auto
Why is ORX down 3,00%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,84 SEK
arrow_downward
-3,00%(-0,026) 1D
13 қар., 10:18:18 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,90 SEK
High
0,90 SEK
Low
0,84 SEK
Mkt. cap
295,07 млн
Avg. vol.
739,90 м.
Volume
325,68 м.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,90 SEK
High
0,90 SEK
Low
0,84 SEK
Mkt. cap
295,07 млн
Avg. vol.
739,90 м.
Volume
325,68 м.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
MarketWatch
·
25 минут бұрын
Stock Market Today: Dow, S&P 500 and Nasdaq set for flat to weaker start as investors digest Nvidia turmoil, await PPI data: live updates
marketscreener.com
·
4 сағат бұрын
S&P 500 index fell after the Stockholm market closed Thursday
TradingView
·
2 сағат бұрын
SPX: S&P 500 Futures Edge Higher After Nvidia Crisis, 10-Year Yield Hits 5.14%
Traders Union
·
11 сағат бұрын
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com